4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/KU-55933/SYN-1051-M010/10 mg
商品详细Adipogen/KU-55933/SYN-1051-M010/10 mg
Adipogen/KU-55933/SYN-1051-M010/10 mg
Adipogen/KU-55933/SYN-1051-M010/10 mg
商品编号: SYN-1051-M010
品牌: Adipogen Inc
市场价: ¥2600.00
美元价: 1560.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
More Information
Product Details
Synonyms KU55933
Product Type Chemical
Properties
Formula C21H17NO3S2
MW 395.5
CAS 587871-26-9
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: ATM/ATR | Kinase Group: Atypical (PIKK) | Substrate: Serine-Threonine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key XRKYMMUGXMWDAO-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
KU55933 is a potent and selective ATP-competitive inhibitor of ATM, with an IC(50) of 13nM and a Ki of 2.2nM. KU55933 has potential for use as a new radio- and chemo-sensitizing agent for the treatment of cancer.
Product References
  1. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM: I. Hickson, et al.; Cancer Res. 64, 9152 (2004)
  2. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis: J.S. Eaton|et al.; J. Clin. Invest. 117, 2723 (2007)
  3. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy: E. Crescenzi, et al.; Clin. Cancer Res. 14, 1877 (2008)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。